Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol

  • 1, 2,
  • 1,
  • 3,
  • 1,
  • 4, 5 and
  • 1, 2Email author
Trials201718:214

https://doi.org/10.1186/s13063-017-1930-7

  • Received: 6 April 2017
  • Accepted: 6 April 2017
  • Published:

The original article was published in Trials 2013 14:51

Erratum

In the original publication [1] the last sentence under the paragraph “Adverse event management” not correct. The correct version can be found here:

“SAEs that occur between trial entry and up to 28 days after completion of the study drug will be reported”.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Centre for Infection and Immunity, The Queen’s University of Belfast, Health Sciences, Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland
(2)
Regional Intensive Care Unit, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland
(3)
Clinical Research Support Centre, Royal Victoria Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland
(4)
Cardiovascular Research Institute, University of California, San Francisco, 505 Parnassus Avenue, M-917, San Francisco, CA 94143-0624, USA
(5)
Departments of Medicine and Anesthesia, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA

Reference

  1. McAuley DF. Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol. Trials. 2013;14:10.1186/1745-6215-14-51.Google Scholar

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement